Skip to main content
OpenTrials

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

246 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Completed

A Study to Evaluate P1101 in Japanese PV Patients

NCT06002490

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +7 more
Locations
  • Mie University Hospital Mie, Japan
  • Osaka University Hospital Osaka, Japan
  • Kansai Medical University Hospital Osaka, Japan
  • Juntendo University Hospital Tokyo, Japan
View Trial Details
Completed

The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

NCT03640325

Conditions
Adherence, Medication, Adolescent Behavior, Anxiety, +20 more
Locations
  • University of Alabama, Birmingham Birmingham, Alabama, United States
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • Dana-Farber/Harvard Cancer Center Boston, Massachusetts, United States
  • St. Jude Children's Research Hospital Memphis, Tennessee, United States
View Trial Details
Completed

The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PV

NCT03003325

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • U.O. Ematologia, Ospedale Casa Sollievo della Sofferenza Istituto di Ricovero e Cura a Carattere Scientifico San Giovanni Rotondo, (FG) Puglia, Italy
  • U.O. Ematologia con Trapianto, Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari Bari, Apulia, Italy
  • Azienda Ospedaliera Universitaria Federico II di Napoli Naples, Campania, Italy
  • Divisione Ematologia Policlinico S. Orsola - Malpighi Bologna, Emilia-Romagna, Italy
View all 23 locations
View Trial Details
Completed

A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

NCT03859427

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Bone Marrow Neoplasms, +21 more
Locations
  • Robert A Moss Oncology Fountain Valley, California, United States
  • Rocky Mountain Cancer Centers Denver Midtown Denver, Colorado, United States
  • Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut Plainville, Connecticut, United States
  • Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
View all 108 locations
View Trial Details
Completed

Tagraxofusp in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia

NCT02113982

Conditions
Acute Myeloid Leukemia (AML), Blastic Plasmacytoid Dendritic Cell Neoplasm, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), +14 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • H. Lee Moffiitt Cancer Center & Research Institute Tampa, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View Trial Details
Completed

Clinical and Laboratory Characteristics of Polycythemia Vera

NCT06134102

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Ospedale Casa Sollievo della Sofferenza San Giovanni Rotondo, Apulia, Italy
  • Grande Ospedale Metropolitano "Bianchi Melacrino Morelli" Reggio Calabria, Calabria, Italy
  • IRCCS Policlinico Sant'Orsola Bologna, Emilia-Romagna, Italy
  • Università degli studi di Ferrara - Nuovo Polo Ospedaliero di Cona - A.O.U. Arcispedale S. Anna Ferrara, Emilia-Romagna, Italy
View all 22 locations
View Trial Details
Completed

A Prospective, Non-interventional Study of JAKAVI® (Ruxolitinib) Treatment in Patients With Polycythemia Vera

NCT05853445

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Novartis Investigative Site Heidenheim, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Mannheim, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Reutlingen, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Winnenden, Baden-Wurttemberg, Germany
View all 99 locations
View Trial Details

Related conditions